Fractyl HealthGUTS
About: Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Employees: 84
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
525% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 4
283% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 6
36% more funds holding
Funds holding: 44 [Q2] → 60 (+16) [Q3]
3.55% more ownership
Funds ownership: 50.2% [Q2] → 53.75% (+3.55%) [Q3]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]
44% less capital invested
Capital invested by funds: $117M [Q2] → $65.2M (-$52M) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Morgan Stanley Michael Ulz 25% 1-year accuracy 4 / 16 met price target | 562%upside $10 | Overweight Maintained | 3 Feb 2025 |
Financial journalist opinion









